Labour Relations in the Motor Industry. A Study of Industrial Unrest and an International Comparison. H. A. Turner G. Clack G. Roberts

Autor: Clegg, H. A.

Publikováno v: The Economic Journal, 1967 Sep 01. 77(307), 633-635.

Externí odkaz: https://www.jstor.org/stable/2229011

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer.

Autor: Pruis MA; Department of Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Plummer R; Oncology Department, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle, UK., De Vos F; Department Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands., Angevin E; Drug Development Department (DITEP), Gustave Roussy Institute, Villejuif, France., Prenen H; Department of Medical Oncology, University Hospital Antwerp, Antwerp, Belgium., Forster MD; Department of Oncology, UCL Cancer Institute/ University College London Hospitals NHS Foundation Trust, London, UK., Clack G; Octimet Oncology NV, Belgium., Van der Aa A; Octimet Oncology NV, Belgium., Tjwa M; Octimet Oncology NV, Belgium., Jansen E; Octimet Oncology NV, Belgium., Perera T; Department of Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Octimet Oncology NV, Belgium., Lolkema MP; Department of Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Publikováno v: The oncologist [Oncologist] 2023 Dec 11; Vol. 28 (12), pp. e1248-e1258.

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

Autor: Coombes RC; Imperial College, South Kensington, London, UK., Howell S; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Lord SR; Early Phase Clinical Trials Unit, Department of Oncology, University of Oxford, Oxford, UK., Kenny L; Imperial College, South Kensington, London, UK., Mansi J; Guy's and St Thomas' NHS Foundation Trust, London, UK., Mitri Z; OHSU Knight Cancer Institute, Portland, OR, USA., Palmieri C; University of Liverpool, Liverpool, UK., Chap LI; University of California, Los Angeles, CA, USA., Richards P; Blue Ridge Cancer Center, Salem, VA, USA., Gradishar W; Northwestern University, Chicago, IL, USA., Sardesai S; US Oncology Research, OHC, Cincinnati, OH, USA., Melear J; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA., O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, Dallas, TX, USA., Ward P; US Oncology Research, OHC, Cincinnati, OH, USA., Chalasani P; University of Arizona Cancer Center, Tucson, AZ, USA., Arkenau T; Sarah Cannon Research Institute, London, UK., Baird RD; Cancer Research UK Cambridge Centre, Cambridge, UK., Jeselsohn R; Dana-Farber Cancer Institute, Boston, MA, USA., Ali S; Imperial College, South Kensington, London, UK., Clack G; Carrick Therapeutics, Dublin, Ireland., Bahl A; Carrick Therapeutics, Dublin, Ireland., McIntosh S; Carrick Therapeutics, Dublin, Ireland., Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. matthew.krebs@manchester.ac.uk.

Publikováno v: Nature communications [Nat Commun] 2023 Aug 07; Vol. 14 (1), pp. 4741. Date of Electronic Publication: 2023 Aug 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours

Autor: Dillon, M.T., Boylan, Z., Smith, D., Guevara, J., Mohammed, K., Peckitt, C., Saunders, M., Banerji, U., Clack, G., Smith, S.A., Spicer, J.F., Forster, M.D., Harrington, K.J.

Publikováno v: In Clinical and Translational Radiation Oncology August 2018 12:16-20